EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis

Ankita Jawanpuria, Shruti Asati, Uma Chaudhary

Journal of Medical Microbiology and Infectious Diseases · 01.12.2025 · 13 (4) · 282-290

DOI: 10.66224/jommid.13.4.282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology and Infectious Diseases, online erschienen am 01.12.2025. Verfasst von Ankita Jawanpuria und 2 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Biofilm formation by multidrug-resistant (MDR) bacteria confers increased antimicrobial tolerance and contributes to persistent infections, presenting significant therapeutic challenges.These challenges have driven research into natural compounds that may target key processes, including efflux pump activity, quorum sensing, bacterial adhesion, and biofilm development.This study investigates the anti-biofilm efficacy of six naturally occurring compounds-berberine, chitosan, curcumin, eugenol, linoleic acid, and reserpine-against clinically relevant aerobic MDR bacterial pathogens.

Methods

Biofilm formation was evaluated in 200 MDR clinical isolates, including isolates of Escherichia coli (n=49), Klebsiella pneumoniae (n=46), Acinetobacter baumannii (n=24), Pseudomonas aeruginosa (n=29), Staphylococcus aureus (n=25), and Staphylococcus epidermidis (n=27), sourced from various clinical specimens, including pus, urine, blood, and sputum.Biofilm production was quantified using the modified tissue culture plate (MTCP) method.From these isolates, 36 strong biofilm-forming isolates were selected, and the minimum biofilm inhibitory concentration (MBIC) of each compound was determined via a microtiter plate assay with two-fold serial dilutions.

Results

Of 200 isolates, 101 (50.5%) exhibited biofilm formation.MBIC values ranged from 0.0156 mg/mL (lowest for eugenol against E. coli and reserpine against E. coli, K. pneumoniae, and S. aureus) to 1 mg/mL (for curcumin against P. aeruginosa and A. baumannii).Eugenol and reserpine showed significantly lower MBICs compared to curcumin (P < 0.05).Eugenol displayed the lowest mean MBIC (0.049 mg/mL) across the 36 selected strong biofilm-forming isolates, followed by reserpine (0.070 mg/mL), while curcumin exhibited the highest mean MBIC (0.583 mg/mL).Linoleic acid demonstrated its lowest MBIC (0.0312 mg/mL) against K. pneumoniae.

Conclusion

The tested compounds exhibited variable antibiofilm potency, with eugenol and reserpine demonstrating the greatest efficacy and curcumin the least, suggesting limited anti-biofilm efficacy at tested concentrations.These findings underscore the potential of eugenol, reserpine, linoleic acid, berberine, and chitosan as promising in vitro antibiofilm candidates for managing biofilm-associated infections caused by MDR bacteria; however, in vivo efficacy, pharmacokinetics, and safety warrant further investigation in animal models and clinical trials. ACKNOWLEDGMENTThe authors acknowledge the technical staff of the Department of Microbiology, Postgraduate Institute of Medical Sciences (PGIMS), Rohtak, for their assistance during sample collection and laboratory work.

Zitieren

APA

Jawanpuria, A., Asati, S., & Chaudhary, U. (2025). Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis. Journal of Medical Microbiology and Infectious Diseases, 13(4), 282-290. https://doi.org/10.66224/jommid.13.4.282

Vancouver

Jawanpuria A, Asati S, Chaudhary U. Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis. Journal of Medical Microbiology and Infectious Diseases. 2025;13(4):282-290. doi:10.66224/jommid.13.4.282

BibTeX
@article{Jawanpuria2025,
  author = {Jawanpuria, Ankita and Asati, Shruti and Chaudhary, Uma},
  title = {Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis},
  journal = {Journal of Medical Microbiology and Infectious Diseases},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {282--290},
  doi = {10.66224/jommid.13.4.282}
}
Kostenlos starten →